Home›Trial›NCT05478304
🔬NCT05478304NAACTIVE NOT RECRUITING

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial

Study Summary

This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.

Conditions
Ischemic StrokeSystemic Embolism
Interventions / Drugs
AtriClip LAA Exclusion System
View on ClinicalTrials.gov ↗
Sponsor
ATRC
AtriCure Inc
Cardiac Surgery
D36/100
Study Details
Enrollment6573 participants
Primary Completion—
Lead SponsorAtriCure, Inc.
Data Retrieved2026-04-11 02:55:07.545226+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.